Is it time to challenge the established theories surrounding type 1 diabetes?

被引:4
|
作者
Ludvigsson, Johnny [1 ]
机构
[1] Linkoping Univ, Dept Clin Expt Med, Div Pediat, SE-58185 Linkoping, Sweden
关键词
Aetiology; Autoimmunity; Pathogenesis; Type; 1; diabetes; 2; ANTI-CD3; MONOCLONAL-ANTIBODY; BETA-CELL FUNCTION; DOUBLE-BLIND; C-PEPTIDE; ONSET; MELLITUS; DIAGNOSIS; CHILDREN; RESPONSES; PANCREAS;
D O I
10.1111/apa.12452
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Type one diabetes (T1D) seems a well-defined disease, but its classification may be difficult. Evidence is weak that an autoimmune process with insulitis causes loss of the beta cells in all patients. Some scientists propose that it may be caused by a virus, increased hygiene or the early introduction of cow's milk or gluten, while views about the nerve supply, vascular function and the beta cells own role tend to be disregarded. Immune interventions have had limited success. There are differences, but also similarities, between T1D and type 2 diabetes (T2D). ConclusionSeveral views on T1D have become so widely accepted that they may actually hamper progress into the true cause of this disease. Research on T1D needs to be carried out with an open mind, and clinicians might be wise to recommend a lifestyle that aims to decrease both the risk of T1D and T2D.
引用
收藏
页码:120 / 123
页数:4
相关论文
共 50 条
  • [21] Insulitis in type 1 diabetes
    Veld, P. In't
    Kloeppel, G.
    PATHOLOGE, 2016, 37 (03): : 245 - 252
  • [22] The challenge of modulating β-cell autoimmunity in type 1 diabetes
    Atkinson, Mark A.
    Roep, Bart O.
    Posgai, Amanda
    Wheeler, Daniel C. S.
    Peakman, Mark
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (01) : 52 - 64
  • [23] Diabetic ketoacidosis at diagnosis of type 1 diabetes and glycemic control over time: The SEARCH for diabetes in youth study
    Duca, Lindsey M.
    Reboussin, Beth A.
    Pihoker, Catherine
    Imperatore, Giuseppina
    Saydah, Sharon
    Mayer-Davis, Elizabeth
    Rewers, Arleta
    Dabelea, Dana
    PEDIATRIC DIABETES, 2019, 20 (02) : 172 - 179
  • [24] Formation of pancreatic β-cells from precursor cells contributes to the reversal of established type 1 diabetes
    Ukah, Tobechukwu K.
    Cattin-Roy, Alexis N.
    Davis, George E.
    Zaghouani, Habib
    CELLULAR IMMUNOLOGY, 2021, 364
  • [25] DiaPep277 peptide therapy in the context of other immune intervention trials in type 1 diabetes
    Tuccinardi, Dario
    Fioriti, Elvira
    Manfrini, Silvia
    D'Amico, Eugenio
    Pozzilli, Paolo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (09) : 1233 - 1240
  • [26] Immunotherapy in type 1 diabetes: Novel pathway to the future ahead
    Ray, Sayantan
    Palui, Rajan
    WORLD JOURNAL OF DIABETES, 2024, 15 (10)
  • [27] What is the role of autoimmunity in type 1 diabetes? A clinical perspective
    Donath, Marc Y.
    Hess, Christoph
    Palmer, Ed
    DIABETOLOGIA, 2014, 57 (04) : 653 - 655
  • [28] Pancreatic shear wave elastography in children with type 1 diabetes: relation to diabetes duration, glycemic indices, fasting C-peptide and diabetic complications
    Salah, Nouran Yousef
    Madkour, Sherihane Said
    Soliman, Khaled Sayed
    PEDIATRIC RADIOLOGY, 2022, 52 (12) : 2348 - 2358
  • [29] Challenges in developing endpoints for type 1 diabetes intervention studies
    Cernea, Simona
    Raz, Itamar
    Herold, Kevan C.
    Hirshberg, Boaz
    Roep, Bart O.
    Schatz, Desmond A.
    Fleming, G. Alexander
    Pozzilli, Paolo
    Little, Randie
    Schloot, Nanette C.
    Leslielo, R. David G.
    Skyler, Jay S.
    Palmer, Jerry P.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2009, 25 (08) : 694 - 704
  • [30] The challenge of type 1 diabetes mellitus
    Eiselein, L
    Schwartz, HJ
    Rutledge, JC
    ILAR JOURNAL, 2004, 45 (03) : 231 - 236